Hoth Therapeutics (HOTH) Financial Statements

Hoth Therapeutics's market cap is currently $16.29M. The company's EPS TTM is $-1.337; its P/E ratio is -1.01; Hoth Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.